The Business Research Company’s report on the In-Vitro Toxicology Testing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the in-vitro toxicology testing market in recent years?
Growing healthcare expenditure is expected to propel the in-vitro toxicology testing market going forward. Health expenditure is the amount of money spent by citizens and the government out of total income on hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Health expenditure is increasing in the world due to the rising prevalence of disease which utilizes in-vitro toxicology testing. For instance, in September 2024, according to the report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, from 2023 to 2032, the average growth rate of national health expenditure (NHE) is projected to be 5.6%, surpassing the average GDP growth rate of 4.3%. As a result, the share of health spending as a percentage of GDP is expected to rise from 17.3% in 2022 to 19.7% in 2032. Therefore, the growing healthcare expenditure is driving the in-vitro toxicology testing market.
Access Your Free Sample of the Global In-Vitro Toxicology Testing Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp
What is the projected market size of the in-vitro toxicology testing industry, and how is it expected to grow?
The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $11.53 billion in 2024 to $12.77 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to regulatory requirements, ethical concerns and animal welfare, cost and time efficiency, globalization of the pharmaceutical industry, drug discovery and development demands, public awareness of environmental toxins.
The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $19.18 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to focus on personalized medicine, demand for predictive toxicology models, expansion of environmental testing, oncology drug development challenges, focus on endocrine disruptor screening, shift towards multi-organ chips. Major trends in the forecast period include advancements in 3d cell culture technologies, integration of high-throughput screening, focus on organ-on-a-chip technologies, application in chemical safety assessment, use of human-derived cell lines, incorporation of omics technologies, educational initiatives and training programs.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7987&type=smp
Who are the key players driving competition in the in-vitro toxicology testing market?
Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation
What key trends are expected to drive the intravenous immunoglobulin market during the forecast period?
The development of innovative cell therapy is a key trend gaining popularity in the in-vitro toxicology market. Major companies operating in the in-vitro toxicology testing market are focused on developing new funding solutions to strengthen their position. For instance, in June 2024, Waypoint Bio, a US-based Biotechnology company announced $14.5 million in seed funding for novel cell therapies of solid tumors using in vivo spatial pooled screening technology. The platform uniquely integrates spatial biology with pooled screening, allowing for the simultaneous analysis of how various cell therapy candidates interact with the solid tumor microenvironment. The system measures hundreds of phenotypes at the single-cell level, allowing researchers to understand not only which therapies are effective but also why they succeed or fail based on their interactions within the tumor environment.
Which key geographies are driving the growth of the in-vitro toxicology testing market?
North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
What are the key segments driving growth in the in-vitro toxicology testing market?
The in-vitro toxicology testing market covered in this report is segmented –
1) By Product And Service: Consumables, Assays, Equipment, Software, Services
2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models
3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics
4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications
5) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals
Subsegments:
1) By Consumables: Reagents, Cell Culture Media, Plates And Vials
2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays
3) By Equipment: Automated Systems, Microscopes, Plate Readers
4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software
5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7987
What defines the structure and scope of the in-vitro toxicology testing market?
In-vitro toxicology testing refers to assays and tests used to determine toxic doses of drugs, nutraceuticals, and food additives that cause toxicity when administered. It is used to detect the presence of toxic chemicals, and residual solvents and reduce hazardous exposure. This testing is mostly used to determine the doses of medications that exhibit toxicity in preclinical development, along with drug discovery and development.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
